Evidence map›Paper›PMID 27392810›Full record

ArticleEuropean journal of immunology2016

Expression of heavy chain-only antibodies can support B-cell development in light chain knockout chickens.

Benjamin Schusser, Ellen J Collarini, Darlene Pedersen, Henry Yi, Kathryn Ching, Shelley Izquierdo, Theresa Thoma, Sarah Lettmann, Bernd Kaspers, Robert J Etches and 3 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Comparison of Multiple Strategies for Precision Transgene Knock-In inInternational journal of molecular sciences · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Cas9-expressing chickens and pigs as resources for genome editing in livestock.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  12. Article
  13. Article
  14. Current Approaches and Applications in Avian Genome Editing.International journal of molecular sciences · 2020
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Benjamin SchusserReproductive Biotechnology, Technische Universität München, WZW Center of Life Science, Freising-Weihenstephan, Germany.
Ellen J CollariniCrystal Bioscience Inc, Emeryville, CA, USA.
Darlene PedersenCrystal Bioscience Inc, Emeryville, CA, USA.
Henry YiCrystal Bioscience Inc, Emeryville, CA, USA.
Kathryn ChingCrystal Bioscience Inc, Emeryville, CA, USA.
Shelley IzquierdoCrystal Bioscience Inc, Emeryville, CA, USA.
Theresa ThomaReproductive Biotechnology, Technische Universität München, WZW Center of Life Science, Freising-Weihenstephan, Germany.
Sarah LettmannDepartment of Veterinary Science, Institute for Animal Physiology, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany.
Bernd KaspersDepartment of Veterinary Science, Institute for Animal Physiology, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany.
Robert J EtchesCrystal Bioscience Inc, Emeryville, CA, USA.
Marie-Cecile van de LavoirCrystal Bioscience Inc, Emeryville, CA, USA.
William HarrimanCrystal Bioscience Inc, Emeryville, CA, USA.
Philip A LeightonCrystal Bioscience Inc, Emeryville, CA, USA. pal@crystalbioscience.com.
Tethys Research (United States) · USLudwig-Maximilians-Universität München · DETechnical University of Munich · DE

Funding

Engineered proteins from transgenic animalsR44GM090626 · NIGMS · CRYSTAL BIOSCIENCE, INC. · PI LEIGHTON, PHILIP · 2012 to 2013
$1.8M
Engineered proteins from transgenic animalsR43GM090626 · NIGMS · CRYSTAL BIOSCIENCE, INC. · PI ETCHES, ROBERT · 2010 to 2010
$172k
NIGMS NIH HHS R43 GM090626NIGMS NIH HHS R44 GM090626
6 · The paper itself

Abstract

Since the discovery of antibody-producing B cells in chickens six decades ago, chickens have been a model for B-cell development in gut-associated lymphoid tissue species. Here we describe targeting of the immunoglobulin light chain locus by homologous recombination in chicken primordial germ cells (PGCs) and generation of VJCL knockout chickens. In contrast to immunoglobulin heavy chain knockout chickens, which completely lack mature B cells, homozygous light chain knockout (IgL(-/-) ) chickens have a small population of B lineage cells that develop in the bursa and migrate to the periphery. This population of B cells expresses the immunoglobulin heavy chain molecule on the cell surface. Soluble heavy-chain-only IgM and IgY proteins of reduced molecular weight were detectable in plasma in 4-week-old IgL(-/-) chickens, and antigen-specific IgM and IgY heavy chain proteins were produced in response to immunization. Circulating heavy-chain-only IgM showed a deletion of the CH1 domain of the constant region enabling the immunoglobulin heavy chain to be secreted in the absence of the light chain. Our data suggest that the heavy chain by itself is enough to support all the important steps in B-cell development in a gut-associated lymphoid tissue species.

Indexed as

Gene ExpressionAnimalsAnimals, Genetically ModifiedAntibodiesAntibody FormationB-LymphocytesCell DifferentiationChickensGene DeletionGene Knockout TechniquesGene OrderGene TargetingGenetic VectorsImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsPlasma CellsAntibodiesImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsAntibodiesB-cell developmentImmunoglobulinsKnockout chickens

Identifiers

PMID27392810
PMCPMC5113765
OpenAlexW2474091620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.